Published in Am Heart J on September 01, 1975
Vasodilator treatment for acute and chronic heart failure. Br Heart J (1977) 1.84
Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. Br Heart J (1984) 1.39
Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate. Eur J Clin Pharmacol (1990) 0.81
Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease. Br Heart J (1978) 0.81
Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure. Br Heart J (1979) 0.81
Enhancement by isosorbide dinitrate of haemodynamic effects of dopamine in chronic congestive cardiac failure. Br Heart J (1978) 0.79
Methods for the assessment of the effects of drugs on coronary blood flow in man. Br J Clin Pharmacol (1978) 0.78
Letter: Cardiac failure. Br Med J (1976) 0.75
Effectiveness of isosorbide dinitrate in cyanide poisoning as a function of the administration timing. BMC Pharmacol Toxicol (2017) 0.75
Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure. Br Heart J (1979) 0.75
Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. Br Heart J (1981) 0.75
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure. Can Med Assoc J (1979) 0.75
Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure. Br Heart J (1980) 0.75
Peripheral oedema in patients treated with isosorbide dinitrate. Br Med J (Clin Res Ed) (1981) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med (1979) 9.91
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet (2004) 9.10
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med (1970) 7.27
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol (1996) 4.92
Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet (2000) 4.39
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97
Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol (1995) 3.51
Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J (1981) 3.48
Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG (2007) 3.31
HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS (2001) 3.30
Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation (1971) 3.14
Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol (2000) 3.10
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s? Chest (1999) 2.85
Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med (1973) 2.79
Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med (1990) 2.75
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand (2009) 2.68
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev (1999) 2.57
Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health (1998) 2.53
The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation (1993) 2.51
Intracoronary thrombolysis in evolving myocardial infarction. Am Heart J (1981) 2.43
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol (1995) 2.33
A new technique for measurement of cardiac output by thermodilution in man. Am J Cardiol (1971) 2.32
Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J (1972) 2.25
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group. J Natl Cancer Inst (1996) 2.25
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol (1999) 2.22
Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol (1990) 2.22
The declining specificity of exercise radionuclide ventriculography. N Engl J Med (1983) 2.22
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res (2003) 2.12
Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation (1973) 2.08
Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol (1984) 2.08
Large-scale randomized evidence: large, simple trials and overviews of trials. Ann N Y Acad Sci (1993) 2.08
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation (2000) 2.07
Measurement of blood flow by thermodilution. Am J Cardiol (1972) 2.06
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation (1980) 2.02
Filling pressures in the right and left sides of the heart in acute myocardial infarction. A reappraisal of central-venous-pressure monitoring. N Engl J Med (1971) 2.00
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem (2003) 1.97
National study of colorectal cancer genetics. Br J Cancer (2007) 1.92
Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res (1991) 1.92
Vitamin D metabolism: the role of kidney tissue. Science (1971) 1.91
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol (1991) 1.91
Electrocardiographic changes subsequent to artificial ventricular depolarization. Br Heart J (1969) 1.88
Vasodilator treatment for acute and chronic heart failure. Br Heart J (1977) 1.84
Heart-block following acute myocardial infarction. Treatment with demand and fixed-rate pacemakers. Lancet (1968) 1.77
Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry (2001) 1.75
Comparison of transesophageal echocardiographic and scintigraphic estimates of left ventricular end-diastolic volume index and ejection fraction in patients following coronary artery bypass grafting. Anesthesiology (1990) 1.75
Diastolic pressure-volume relationship in the canine left ventricle. Circ Res (1971) 1.74
Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care (2004) 1.74
Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol (2000) 1.73
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med (1989) 1.70
Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med (1989) 1.70
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation (2000) 1.69
The hemodynamics of common (or single) ventricle. Circulation (1966) 1.69
The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis (1977) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Angiographic validation of bedside markers of reperfusion. J Am Coll Cardiol (1993) 1.67
Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group. Genitourin Med (1997) 1.66
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol (1994) 1.66
Heart failure therapy in evolution. Circulation (1996) 1.64
Effects of isometric exercise on cardiac performance. The grip test. Circulation (1971) 1.63
The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J (1979) 1.63
Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med (1980) 1.63
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial. Lancet Neurol (2008) 1.62
Noradrenaline and beta-adrenoceptor agonists increase activity of voltage-dependent calcium channels in hippocampal neurons. Nature (1987) 1.62
Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation (1991) 1.61
Effect of coronary artery disease and acute myocardial infarction on left ventricular compliance in man. Circulation (1972) 1.60